Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experience

Characteristics and outcomes of patients with advanced hepatocellular carcinoma treated on phase I trials.

(2017) Ishwaria Mohan Subbiah et al.   JOURNAL OF CLINICAL ONCOLOGY

End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article

(2013) Hans Wildiers et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer and Age: General Considerations

(2012) Sarah Hoffe et al.   CLINICS IN GERIATRIC MEDICINE

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

(2011) Elisabeth Quoix et al.   LANCET

Participation and survival of geriatric patients in Phase I clinical trials: The Karmanos Cancer Institute (KCI) experience

(2010) Syed F. Zafar et al.   Journal of Geriatric Oncology

Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy

(2009) Noelle K. LoConte et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials

(2009) Hendrik-Tobias Arkenau et al.   JOURNAL OF CLINICAL ONCOLOGY

Dying with cancer

(2008) Wayne S. Kendal   CANCER